According to VYNE Therapeutics's latest financial reports the company's current earnings (TTM) are -โฌ27.84 M. In 2023 the company made an earning of -โฌ26.41 M an increase over its 2022 earnings that were of -โฌ30.74 M.The earnings displayed on this page is the company's Pretax Income.